The ROE as of October 2024 (TTM) for Milestone Pharmaceuticals Inc. (MIST) is -165.26%

According to Milestone Pharmaceuticals Inc.’s latest financial reports and current stock price. The company's current ROE is -165.26%. This represents a change of 249.23% compared to the average of -47.32% of the last 4 quarters.

Milestone Pharmaceuticals Inc. (MIST) Historical ROE (quarterly & annually)

How has MIST ROE performed in the past?

The mean historical ROE of Milestone Pharmaceuticals Inc. over the last ten years is -70.92%. The current -165.26% ROE has changed 133.03% with respect to the historical average. Over the past ten years (40 quarters), MIST's ROE was at its highest in in the December 2022 quarter at 27.52%. The ROE was at its lowest in in the December 2023 quarter at -81.16%.

Milestone Pharmaceuticals Inc. (MIST) ROE by Quarter and Year

Discovering the peaks and valleys of Milestone Pharmaceuticals Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Milestone Pharmaceuticals Inc. (MIST) Average ROE

How has MIST ROE performed in the past?

The current ROE of Milestone Pharmaceuticals Inc. (MIST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Milestone Pharmaceuticals Inc. (MIST) ROE vs. Peers

How is MIST’s ROE compared to its peers?

Milestone Pharmaceuticals Inc.’s ROE is greater than DiaMedica Therapeutics Inc. (-38.56%), less than Seres Therapeutics, Inc. (313.56%), greater than Inhibikase Therapeutics, Inc. (-194.17%), greater than Oncolytics Biotech Inc. (-114.55%), greater than scPharmaceuticals Inc. (-201.84%), greater than aTyr Pharma, Inc. (-56.83%), less than X4 Pharmaceuticals, Inc. (32.93%), less than Galera Therapeutics, Inc. (21.95%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than HOOKIPA Pharma Inc. (-51.77%), less than Spero Therapeutics, Inc. (20.70%), greater than Bolt Biotherapeutics, Inc. (-61.40%), less than Coherus BioSciences, Inc. (23.81%), greater than Gracell Biotechnologies Inc. (-37.20%), greater than Neoleukin Therapeutics, Inc. (-47.64%), greater than Monte Rosa Therapeutics, Inc. (-70.40%), greater than NewAmsterdam Pharma Company N.V. (-86.66%), less than Inventiva S.A. (550.46%), greater than Cullinan Oncology, Inc. (-28.37%), greater than Compass Therapeutics, Inc. (-28.67%),

Build a custom stock screener for Milestone Pharmaceuticals Inc. (MIST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Milestone Pharmaceuticals Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Milestone Pharmaceuticals Inc. (MIST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Milestone Pharmaceuticals Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.